Showing results (21-30 of 25) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Journal of Neurotrauma|March 9, 2011
A phase I/IIa clinical trial of a recombinant Rho protein antagonist in acute spinal cord injuryMichael G Fehlings, Nicholas Theodore, James Harrop, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 4, 2024
The novel ROCK2 selective inhibitor NRL-1049 preserves the blood-brain barrier after acute injuryInge A Mulder, Matt Abbinanti, Sarah A Woller, et al.Iscience|May 27, 2022
Self-delivering RNAi compounds as therapeutic agents in the central nervous system to enhance axonal regeneration after injurySarah A Woller, Joerg Ruschel, Barbara Morquette, et al.Translational Stroke Research|August 26, 2019
A Brain-Targeted Orally Available ROCK2 Inhibitor Benefits Mild and Aggressive Cavernous Angioma DiseaseLisa McKerracher, Robert Shenkar, Matthew Abbinanti, et al.Journal of Neurotrauma|February 9, 2021
A Randomized Controlled Trial of Local Delivery of a Rho Inhibitor (VX-210) in Patients with Acute Traumatic Cervical Spinal Cord InjuryMichael G Fehlings, Yang Chen, Bizhan Aarabi, et al.Pageof 3